LGX-818(Encorafenib) 产品说明书 Chemicals
导航 首页 > 产品 > Featured products
产品编号 DC7018
名称 LGX-818(Encorafenib)

化学性质

CAS 1269440-17-6
分子式 C22H27CLFN7O4S
分子量 540.01
存储条件 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

生物活性

Description
In Vivo
In Vitro

化合物的使用

Kinase Assay
Cell Assay
Animal Administration

参考文献


LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis, is in phase III clinical trials, and was disclosed at the spring 2013 American Chemical Society meeting in
退货政策
如果您对于您的订单不满意，您可以在购买日365天内将产品退回。
下订单的时候请提供您的快递地址以及开票信息
电话: +86-21-58447131
传真: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

网址:
http://www.dcbio.cn/